Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Behrend, C. Sunitinib versus Ripretinib beim GIST. Im Fokus Onkologie 26, 12–13 (2023). https://doi.org/10.1007/s15015-023-3047-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15015-023-3047-z